This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 7, No 8 (2018): August

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Authors of this article:

Nikhil Chauhan1 Author Orcid Image ;   Janet Bukovcan1 Author Orcid Image ;   Eveline Boucher1 Author Orcid Image ;   David Cosgrove2 Author Orcid Image ;   Julien Edeline3 Author Orcid Image ;   Bonnie Hamilton1 Author Orcid Image ;   Laura Kulik4 Author Orcid Image ;   Fayaz Master1 Author Orcid Image ;   Riad Salem5, 6, 7 Author Orcid Image
Article Authors Cited by (34) Tweetations (1) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.